Token导航 LogoToken导航

Agent Skill · 效率

biotech-pitch-deck-narrative(生物技术融资演讲稿叙述)

biotech-pitch-deck-narrative 用于补充效率相关能力,适合在 OpenClaw 中需要让 Agent 承接效率相关任务时使用。可结合来源仓库、安装命令和原始 README 继续核验具体用法。安装前建议确认权限范围、维护状态,以及是否会触发联网、命令执行或文件读写。

biotech-pitch-deck-narrative 是效率类 Agent Skill,可用宿主为 OpenClaw,通过ClawHub获取,权限为需要联网;许可证为 MIT-0,第三方扫描有提醒项,按安装量在效率类的 21,003 个 Skill 里排第 8,297。

总安装 7,243周安装 293GitHub Stars 公开资料未说明下载 2,274核验 2026-05-01

安装说明

本站只整理中文说明,不托管安装包,也不代用户安装。
GitHub
许可证
MIT-0
版本
0.1.0

安装方式

通过对话安装

复制提示词发给支持本地命令或 Skills 的 AI 助手,先确认命令和权限,再让它执行。

请帮我安装这个 Agent Skill:biotech-pitch-deck-narrative(生物技术融资演讲稿叙述)
来源仓库:https://github.com/aipoch-ai/biotech-pitch-deck-narrative
安装命令:
openclaw skills install biotech-pitch-deck-narrative
安装前请先检查当前环境是否支持对应 CLI,并向我确认将要执行的命令、安装目录、联网范围和文件读写权限;确认后再执行。

命令行安装

复制命令到本机终端执行。该命令会通过 OpenClaw 从第三方来源获取 Skill;本站只展示命令,不托管安装包,也不自动执行。

ClawHubOpenClaw
openclaw skills install biotech-pitch-deck-narrative

这个 Skill 是做什么的

效率类 Skill 把重复的整理、汇总、转换工作交给助手完成,减少手工复制粘贴。

biotech-pitch-deck-narrative帮助制作生物技术融资演讲稿。适用于投资者沟通和科学数据翻译场景。支持筹款演示准备和投资者问答制定。biotech-pitch-deck-narrative 属于效率类 Skill,可作为该场景下的辅助能力补充。使用前需确认技术细节和商业价值点。

建议了解具体的叙事结构和重点突出方法。

上手步骤

4 步
  1. 1

    确认自己的宿主工具

    公开资料标注支持 OpenClaw;先确认自己用的是其中之一,再按对应工具的 Skills 目录放置。

  2. 2

    拿到安装命令

    可以直接复制的命令是 openclaw skills install biotech-pitch-deck-narrative;命令里的占位符换成自己的路径或密钥再执行。

  3. 3

    安装后重启宿主

    命令执行完要完全退出宿主工具再打开,让新装的 Skill 被重新扫描到,否则列表里可能看不到。

  4. 4

    按最小权限试用

    它需要需要联网,先在测试目录或测试账号里跑,确认没问题再放到正式项目。

常见问题

6 条

biotech-pitch-deck-narrative 怎么安装?

在终端执行 openclaw skills install biotech-pitch-deck-narrative。装完完全退出宿主工具再打开,让它重新扫描本地 Skill。

biotech-pitch-deck-narrative 支持哪些 AI 工具?

公开资料标注支持 OpenClaw。其他工具只要能读取本地 Skill 目录,一般也能手动放进去,但要自己确认触发方式是否一致。

biotech-pitch-deck-narrative 需要什么权限?

权限级别是需要联网。该 Skill 可能需要联网访问来源站点、仓库或外部 API;具体网络访问范围需要结合源码和 README 复核。

biotech-pitch-deck-narrative 是免费的吗?

来源标注的许可证是 MIT-0。本站不代收任何费用,也不托管安装包;能否商用、要不要署名,以许可证原文为准。

biotech-pitch-deck-narrative 用的人多吗?

公开数据是累计安装 7,243 次,近一周安装 293 次,下载 2,274 次。这些数字来自第三方目录统计,只能当作热度参考,不代表质量或安全性。

biotech-pitch-deck-narrative 安全吗?

第三方扫描有提醒项,说明存在需要人工确认的行为。安装前请打开源码看清它读了什么、联网到哪里。

值得选的地方和要先想清楚的地方

值得选的地方

  • 专注 OpenClaw 一种宿主,触发方式和使用习惯不用来回切换。
  • 许可证明确为 MIT-0,商用和分发边界好判断。

先想清楚的地方

  • 第三方扫描存在提醒项或未通过项,需要人工逐条确认。
  • 第三方目录整理,版本更新和行为细节以来源仓库为准。

适不适合你

更适合

  • 已经在用 OpenClaw,想直接扩展它能力的人。
  • 需要处理效率类任务、又不想每次都手写提示词的人。

不太适合

  • 需要厂商级技术支持和 SLA 的生产系统。

效率类 Skill 对比

6 个同类
Skill总安装GitHub 星权限许可证扫描
github

GitHub 代码协作 · OpenClaw

7,632,918545需要联网MIT-0通过
nano-pdf

Nano PDF 文档 · OpenClaw

4,249,476231需要联网MIT-0通过
auto-updater

自动更新程序 · OpenClaw

2,964,063386操作浏览器MIT-0通过
video-frames

视频帧 · OpenClaw

2,621,304112需要联网MIT-0通过
gemini

Gemini 助手 · OpenClaw

2,547,39648需要联网MIT-0有提醒
biotech-pitch-deck-narrative

生物技术融资演讲稿叙述 · 本页

7,243—需要联网MIT-0有提醒

按安装量取同分类前几名;数字来自第三方目录统计,只作热度参考,不代表质量结论。

SKILL.md 原文

name
biotech-pitch-deck-narrative
description
Use when creating biotech pitch decks, translating scientific data for investors, preparing fundraising presentations, or developing investor Q&A. Transforms complex scientific and clinical data into compelling investor narratives for biotech fundraising.
allowed-tools
Read Write Bash Edit
license
MIT
metadata
skill-author
AIPOCH
version
1.0

Biotech Pitch Deck Narrative

Overview

Strategic communication tool that translates complex biotechnology innovations into compelling business narratives optimized for venture capital, pharmaceutical partnerships, and public market investors.

Key Capabilities:

  • Science Translation: Convert technical data into business value language
  • Narrative Architecture: Structure Problem→Solution→Market→Traction→Vision flow
  • Stage Optimization: Tailor messaging for seed through IPO fundraising
  • Investor Calibration: Adapt for generalist vs. specialist audiences
  • Risk Mitigation: Frame scientific and regulatory risks as manageable challenges
  • Q&A Preparation: Anticipate investor questions and prepare responses

When to Use

✅ Use this skill when:

  • Preparing Series A/B pitch decks for VC presentations
  • Creating management presentations for IPO roadshows
  • Developing BD materials for pharma partnership discussions
  • Crafting executive summaries for grant applications
  • Rehearsing investor Q&A for earnings calls
  • Translating clinical data into commercial narratives
  • Adapting academic presentations for business audiences

❌ Do NOT use when:

  • Scientific conference presentations → Use technical language
  • Regulatory submission documents → Use formal FDA/EMA formats
  • Internal R&D team communications → Use full scientific detail
  • Patent applications → Use precise legal/scientific terminology
  • Patient-facing materials → Use lay-summary-gen

Integration:

  • Upstream: market-access-value (commercial assessment), competitor-trial-monitor (competitive landscape)
  • Downstream: business-model-canvas (strategy development), investor-relations-prep (ongoing communications)

Core Capabilities

1. Science-to-Business Translation

Convert technical concepts into investor-friendly language:

from scripts.narrative_engine import BiotechNarrativeEngine

engine = BiotechNarrativeEngine()

# Translate technical description
translation = engine.translate_science(
    technical_description="""
    Our proprietary AAV9-based gene therapy utilizes a codon-optimized 
    transgene under control of a liver-specific promoter to restore 
    functional enzyme in patients with MPS I deficiency.
    """,
    audience="generalist_vc",
    preserve_accuracy=True
)

print(translation.business_narrative)
# "One-time gene therapy delivering a functional copy of the missing enzyme, 
#  potentially curing MPS I rather than managing symptoms"

Translation Strategies:

Technical ConceptBusiness TranslationWhy It Works
"CRISPR-Cas9 gene editing""Precision genetic medicine platform"Platform implies scalability
"Phase II clinical data""De-risked asset with human proof-of-concept"Reduces perceived risk
"Off-target effects""Industry-leading specificity profile"Competitive framing
"MOA via JAK-STAT pathway""Novel mechanism addressing root cause"Value proposition

2. Narrative Architecture

Structure pitch deck flow for maximum impact:

# Generate complete narrative arc
narrative = engine.build_narrative(
    company_stage="series_b",
    science_type="gene_therapy",
    clinical_stage="phase_2",
    target_market="rare_disease",
    key_differentiation="one_time_cure"
)

# Access each component
print(narrative.hook)           # Opening grab
print(narrative.problem)        # Market pain point
print(narrative.solution)       # Your approach
print(narrative.traction)       # Validation to date
print(narrative.ask)            # Funding request

Narrative Structure:

  1. Hook (30 seconds): Why this, why now, why you
  2. Problem ($B+ market): Unmet medical need, current standard limitations
  3. Solution: Your technology/platform, mechanism of action
  4. Traction: Clinical data, partnerships, validation
  5. Market: Size, competition, your advantage
  6. Team: Track record, why you'll succeed
  7. Ask: Funding amount, use of proceeds, milestones

3. Stage-Specific Optimization

Calibrate message depth for funding round:

# Optimize for different stages
seed_narrative = engine.optimize_for_stage(
    base_narrative=narrative,
    stage="seed",
    focus="team_and_vision"  # Seed cares about team and big idea
)

series_a_narrative = engine.optimize_for_stage(
    base_narrative=narrative,
    stage="series_a",
    focus="proof_of_concept"  # Series A needs validation
)

ipo_narrative = engine.optimize_for_stage(
    base_narrative=narrative,
    stage="ipo",
    focus="commercial_readiness"  # IPO requires near-term revenue
)

Stage Requirements:

StageKey QuestionsFocus Areas
Seed ($500K-$2M)Can you execute?Team, vision, early validation
Series A ($10-30M)Does it work?POC data, IP position, market entry
Series B ($30-75M)Will it scale?Phase 2/3 data, BD traction, team expansion
Series C/IPO ($100M+)Commercial executionRegistration trials, launch prep, revenue path

4. Investor Audience Calibration

Adapt tone and depth for different investor types:

# Calibrate for specific investor
calibrated = engine.calibrate_for_audience(
    narrative=narrative,
    investor_type="healthcare_vc",  # vs "generalist_vc" or "pharma_corp"
    technical_depth="moderate",      # Depth of scientific detail
    risk_tolerance="high"            # Early vs late stage framing
)

Investor Types:

  • Generalist VC: Focus on market size, business model, team pedigree
  • Healthcare VC: Balance science rigor with commercial potential
  • Pharma BD: Emphasize strategic fit, validation data, partnership potential
  • Public Market: Highlight near-term catalysts, revenue projections, risk mitigation

Common Patterns

Pattern 1: Clinical-Stage Therapeutics

Scenario: Phase 2 biotech raising Series B.

# Generate complete pitch narrative
python scripts/main.py \
  --science "Small molecule inhibitor targeting mutant KRAS G12C" \
  --stage "phase_2" \
  --indication "lung_cancer" \
  --data "ORR 45%, median PFS 6.5 months" \
  --competition "Mirati, J&J" \
  --output series_b_narrative.json

Narrative Elements:

  • Problem: KRAS mutations in 30% of cancers; previously "undruggable"
  • Solution: First-in-class covalent inhibitor with superior selectivity
  • Traction: Phase 2 data showing 45% response rate, durable responses
  • Market: $15B+ opportunity across multiple tumor types
  • Differentiation: Best-in-class potency, favorable safety profile
  • Ask: $75M to complete Phase 3 and prepare NDA

Pattern 2: Platform Company

Scenario: Novel delivery platform company raising seed.

platform_narrative = engine.generate_platform_narrative(
    platform_technology="Lipid nanoparticle for CNS delivery",
    differentiator="Crosses BBB with 50x improvement over existing LNPs",
    applications=["Alzheimer's", "Parkinson's", "brain_cancer"],
    stage="seed",
    target="platform_value_creation"
)

Platform Story Arc:

  • Platform Thesis: Solving delivery problem unlocks multiple indications
  • Validation: Proof-of-mechanism in 2+ disease models
  • Breadth: Pipeline across CNS, oncology, rare disease
  • **Partnership Appeal": Pharma interest in accessing CNS targets
  • Scalability: Manufacturing platform supports multiple assets

Pattern 3: MedTech Device

Scenario: Surgical robotics company Series A.

device_narrative = engine.generate_device_narrative(
    device_type="surgical_robot",
    clinical_benefit="50% reduction in complications, 30% faster recovery",
    regulatory_path="510k_de_novo",
    reimbursement="CPT_code_established",
    stage="series_a"
)

Device-Specific Elements:

  • Clinical Evidence: Superior outcomes vs. standard of care
  • Economic Value: Cost savings to healthcare system
  • Regulatory Clarity: Clear FDA pathway, reimbursement strategy
  • Adoption Strategy: Training, support, key opinion leader engagement

Pattern 4: Pharma Partnership Pitch

Scenario: Out-licensing asset to big pharma.

# Generate BD materials
python scripts/main.py \
  --mode partnership \
  --asset "Phase 2 ready asset" \
  --indication "NASH" \
  --data_package "Phase 1b complete, biomarker validated" \
  --partner_profile "novo_nordisk" \
  --output bd_presentation.json

Partnership Framing:

  • Strategic Fit: Complements partner's metabolism franchise
  • Validation: De-risked with human proof-of-mechanism
  • Value Creation: $500M+ peak sales potential
  • Deal Structure: Flexible partnership terms proposed

Complete Workflow Example

Building comprehensive fundraising materials:

from scripts.narrative_engine import BiotechNarrativeEngine
from scripts.slide_generator import SlideGenerator
from scripts.qa_prep import QAPreparation

# Initialize
engine = BiotechNarrativeEngine()
slides = SlideGenerator()
qa = QAPreparation()

# Step 1: Generate core narrative
narrative = engine.build_narrative(
    company_stage="series_a",
    therapeutic_area="oncology",
    modality="cell_therapy",
    clinical_stage="phase_1",
    key_differentiation="allogeneic_off_the_shelf"
)

# Step 2: Create slide-by-slide guidance
slide_guide = slides.generate_guide(
    narrative=narrative,
    n_slides=12,
    include_visual_suggestions=True
)

# Step 3: Prepare Q&A
qa_prep = qa.generate_qa(
    narrative=narrative,
    investor_type="healthcare_vc",
    depth="comprehensive"
)

# Step 4: Export complete package
engine.export_package(
    narrative=narrative,
    slides=slide_guide,
    qa=qa_prep,
    output_dir="series_a_pitch_package/"
)

Quality Checklist

Narrative Quality:

  • [ ] Opening hook grabs attention in 30 seconds
  • [ ] Problem is a $B+ market with clear unmet need
  • [ ] Solution is differentiated vs. competition
  • [ ] Traction validates technical and commercial hypotheses
  • [ ] Team has relevant track record
  • [ ] Ask is specific with clear milestones

Translation Accuracy:

  • [ ] Scientific claims remain accurate after simplification
  • [ ] No misleading statements or exaggerated claims
  • [ ] Risk factors disclosed appropriately
  • [ ] Regulatory pathway is realistic
  • [ ] Market size assumptions are defensible

Investor Alignment:

  • [ ] Appropriate for stage and investor type
  • [ ] Addresses likely investor concerns proactively
  • [ ] Financial projections are reasonable
  • [ ] Exit strategy is credible

Before Presentation:

  • [ ] CRITICAL: Legal review of all claims
  • [ ] CRITICAL: Scientific accuracy check by domain expert
  • [ ] Rehearsed with feedback from experienced biotech investors
  • [ ] Backup slides prepared for detailed questions

Common Pitfalls

Translation Errors:

  • ❌ Oversimplification → "Our drug cures cancer" (misleading)

- ✅ "Our drug showed tumor shrinkage in 40% of patients"

  • ❌ Jargon overload → Technical terms without explanation

- ✅ Use analogies: "Like a molecular GPS guiding drugs to tumors"

  • ❌ Hiding risks → No mention of side effects or competition

- ✅ Acknowledge risks with mitigation strategies

Narrative Mistakes:

  • ❌ Technology in search of problem → Cool science, no market

- ✅ Start with problem, solution follows naturally

  • ❌ Ignoring competition → "We have no competitors"

- ✅ Acknowledge competition, explain differentiation

  • ❌ Unrealistic projections → $10B revenue in Year 3

- ✅ Conservative estimates with clear assumptions

Stage Mismatch:

  • ❌ Seed deck with Phase 3 projections → Too far ahead

- ✅ Match milestones to stage-appropriate timelines

  • ❌ IPO presentation to seed investors → Wrong focus

- ✅ Tailor depth and emphasis to investor sophistication

References

Available in references/ directory:

  • vc_presentation_best_practices.md - Venture capital pitch guidelines
  • biotech_valuation_models.md - Valuation methodologies by stage
  • regulatory_pathway_guides.md - FDA/EMA approval timelines
  • market_sizing_methodologies.md - TAM/SAM/SOM calculations
  • investor_question_bank.md - Common Q&A by investor type
  • competitive_landscape_templates.md - Positioning frameworks

Scripts

Located in scripts/ directory:

  • main.py - CLI interface for narrative generation
  • narrative_engine.py - Core story architecture
  • science_translator.py - Technical to business translation
  • slide_generator.py - Deck structure and visual guidance
  • qa_preparation.py - Investor Q&A preparation
  • competitive_analyzer.py - Market positioning analysis
  • risk_framer.py - Risk mitigation messaging
  • stage_optimizer.py - Funding round calibration

Limitations

  • Not Financial Advice: Cannot provide investment recommendations
  • Regulatory Compliance: Does not ensure SEC or other regulatory compliance
  • Market Specificity: May not capture niche investor preferences
  • Real-Time Adaptation: Cannot adjust to live investor reactions
  • Confidentiality: Does not handle material non-public information protection
  • Legal Review: All materials require legal counsel review before use

Parameters

ParameterTypeDefaultRequiredDescription
--sciencestring-Yes*Scientific description of technology
--stagestring-Yes*Funding stage (pre-seed, seed, series-a, etc.)
--audiencestring-Yes*Target audience type (generalist-vc, healthcare-vc, etc.)
--sectionstring-NoSection to rewrite (hook, problem, solution, etc.)
--contentstring-NoContent to rewrite
--inputstring-NoInput file path
--output, -ostring-NoOutput file path

*Required depending on subcommand

Usage

Basic Usage

# Generate narrative from science description
python scripts/main.py generate --science "CRISPR gene therapy for sickle cell" --stage series-a --audience healthcare-vc

# Rewrite specific section
python scripts/main.py rewrite --section technology --content "We use AAV vectors..." --audience generalist-vc

# Analyze existing pitch deck
python scripts/main.py analyze --input pitch.pptx --stage series-a

Risk Assessment

Risk IndicatorAssessmentLevel
Code ExecutionPython script executed locallyLow
Network AccessNo external API callsLow
File System AccessRead/write filesLow
Data ExposureMay process confidential business infoMedium
RegulatoryDoes not ensure SEC complianceMedium

Security Checklist

  • [x] No hardcoded credentials or API keys
  • [x] No unauthorized file system access
  • [x] Output does not expose sensitive information
  • [x] Prompt injection protections in place
  • [x] Error messages sanitized
  • [x] Script execution in sandboxed environment

Prerequisites

# Python 3.7+
# No additional packages required (uses standard library)

Evaluation Criteria

Success Metrics

  • [x] Successfully generates pitch narratives
  • [x] Adapts content to different investor types
  • [x] Rewrites technical content for business audiences
  • [x] Provides stage-appropriate messaging

Test Cases

  1. Generate Narrative: Science description → Complete pitch narrative
  2. Rewrite Section: Technical content → Business-friendly version
  3. Audience Adaptation: Same content for different VC types

Lifecycle Status

  • Current Stage: Draft
  • Next Review Date: 2026-03-06
  • Known Issues: Help text in Chinese
  • Planned Improvements:

- Translate all interface text to English - Add more investor personas - Enhance narrative templates


💼 Business Note: Successful biotech fundraising requires balancing scientific credibility with business appeal. This tool helps structure narratives, but the underlying science and team execution ultimately determine success. Always maintain integrity—overpromising destroys credibility with sophisticated investors.

平台分布

OpenClaw

84.81%
按下载量换算1,929

安全审计

VirusTotal

通过

ClawScan

可疑

Static analysis

通过

权限和风险

需要联网

该 Skill 可能需要联网访问来源站点、仓库或外部 API;具体网络访问范围需要结合源码和 README 复核。

安装前确认

本站仅展示第三方公开信息,不托管安装包,不提供自动安装或运行环境。安装前应自行审查源码、依赖和命令行为。来源安全扫描存在提醒或未通过项,安装前请自行复核。目前只有一个公开来源,建议同时核对源仓库。

继续浏览同类 Skills